NCT07223385: High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
- State
- Under way
- Phase
- Phase 2
- People
- 80 planned
- Started
- 15 Jul 2026
- Primary completion
- Aug 2030
- Arms
- Cardo-Oncolody Referral
- Results
- None posted
- 31 Oct 2025: Trial registered
- 15 Jul 2026: Trial started